Advances in Metabolomics (Technical Insights)

 

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This research service analyzes the global trends in the metabolomics with a focus on the current and prospective applications of this platform.

Table of Contents

Advances in Metabolomics (Technical Insights), Executive SummaryScope and MethodologyScope and Segmentation of the Research ServiceResearch MethodologyOverview of MetabolomicsThe Road to MetabolomicsTechnology Platform for MetabolomicsApplications of MetabolomicsAdvances in Metabolomics (Technical Insights), Assessment of Enabling Technologies--MetabolomicsNoteworthy Innovations in Companies and UniversitiesTracer-Based Metabolomics PlatformBiospectroscopy-Based MetabolomicsChenomx NMR Suite for Analysis of NMR spectraPathway Studio Software for Data AnalysisMetabolomics--Technology ImprovementsSoftware Implemented to Manage Data in Metabolomics StudiesIntegrated Metabolomics Platform Aids in Biomarker DiscoveryMass Spectrometry for Omics StudiesThe KnowItAll Informatics System for Metabolic StudiesAutoNano System for Mass Spectrometry AnalysisNMR Chip for Remote Detection of NMRDrivers and ChallengesDriversChallengesAdvances in Metabolomics (Technical Insights), Assessment of Metabolomics ApplicationsNoteworthy Innovations in Companies and UniversitiesResearchers Hone in on Metabolites to Predict Drug EfficiencyMetabolomic Biomarker Discovery PlatformHighly Integrated State-of-the-Art NMR Spectrometer for Academic and Industry ApplicationsMetabolic Profiling to Determine Human Embryo ViabilityStem Cells and Metabolomics--New Avenues in Biomarker DiscoveryApplication-Oriented Version of HPLCOxidative Stress Markers in Cardiovascular DiseasesDrivers and ChallengesDriversChallengesAdvances in Metabolomics (Technical Insights), Strategic Evaluation of the Competitive EnvironmentAHP--Prioritization of Metabolomics Technologies--CriteriaDefinition of CriteriaSnapshot of Assessment Criteria Used for EvaluationAHP--Prioritization of Metabolomics Technologies--Computation and Analyst InsightsAHP Process and Computation for Goal Node and Level 0 CriteriaAHP Process and Computation for Goal Node and Level 1 CriteriaFinal Priorities and Analyst InsightsAdvances in Metabolomics (Technical Insights), Patents and Database of Key Industry ParticipantsPatentsIndustry PatentsAcademic PatentsKey ParticipantsCompaniesUniversitiesAdvances in Metabolomics (Technical Insights), Decision Support DatabaseDatabase TablesGlobal R&D Investment for Biotechnology (2002 to 2012)Percent Government R&D Investment in Biotechnology (2002 to 2012)Global Pharmaceutical R&D Expenditure (2002 to 2012)Global Percentage Pharmaceutical R&D Expenditure (2002 to 2012)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Release Date : 29-Nov-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.